Recurrent pretibial edema associated with zuclopenthixol acetate: A case report

Zuclopenthixol acetate is an injectable depot antipsychotic that is effective for 24-48 hours and mainly used for the treatment of acute mania or psychotic episodes. To our knowledge, there is only one case report reporting edema after zuclopenthixol use, which described a patient had suffered from facial and peripheral edema after zuclopenthixol decanoate injection. Here, we present a patient with bipolar disorder who developed bilateral pretibial edema following repeated zuclopenthixol acetate injections. A 53-year-old male patient with no previous medical history presented with manic symptoms. Based on his past psychiatric treatment history, zuclopenthixol acetate was initiated, and three positive pretibial edema developed bilaterally after administration. Although no pathological findings to explain edema were detected, the Naranjo Adverse Reaction Probability Scale showed a “probable” relationship of zuclopenthixol and edema with a score of 8. Peripheral edema may develop due to various common medical conditions including antipsychotic drugs and can be life-threatening. Although the exact mechanisms of peripheral edema due to antipsychotic use are still unknown, further studies may shed further light on these mechanisms.

PDF

___

1. Fenton M, Coutinho ES, Campbell C. Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses. Cochrane Database Syst Rev 2001; 3:CD000525. [CrossRef]

2. Barnes CW, Alderton D, Castle D. The development of clinical guidelines for the use of zuclopenthixol acetate. Australas Psychiatry 2002; 10:54-58. [CrossRef]

3. Orum MH. Antipsychotic drugs and peripheral edema: A review. Med Records 2020; 2:39-43. [Turkish] [CrossRef]

4. Orum M, Kara M. Facial and Peripheral Edema Associated with Zuclopenthixol Decanoate Longacting Injectable: A case report. Med J West Black Sea 2019; 3:26-29.[CrossRef]

5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245. [CrossRef]

6. Cho S, Atwood JE. Peripheral edema. Am J Med 2002; 113:580- 586.[CrossRef]

7. Umar MU, Abdullahi AT. Self-limiting Atypical Antipsychoticsinduced Edema: Clinical Cases and Systematic Review. Indian J Psychol Med 2016; 38:182-188.[CrossRef]

8. Chen HJ, Lin ST, Hsu HC, Cheng KD, Tsang HY. Paliperidonerelated peripheral edema: a case report and review of the literature. J Clin Psychopharmacol 2014; 34:269-271. [CrossRef]

9. Witz L, Shapiro MS, Shenkman L. Chlorpromazine induced fluid retention masquerading as idiopathic oedema. Br Med J (Clin Res Ed) 1987; 294:807-808. [CrossRef]

10. Tamam L, Ozpoyraz N, Unal M. Oedema associated with risperidone: a case report and literature review. Clin Drug Investig 2002; 22:411-414. [CrossRef]

11. Ng B, Postlethwaite A, Rollnik J. Peripheral oedema in patients taking olanzapine. Int Clin Psychopharmacol 2003; 18:57-59.

12. Talaei A, Faraji Rad S, Borhani Moghani M, Talaei A. Acquired angioedema ınduced by risperidone. Iran J Psychiatry Behav Sci 2018; 12:e4807.

13. Javed Q, Chorghade A, Javed S, Pervez Y. Reduction in selfharming behaviour after zuclopenthixol decanoate. Prog Neurol Psychiatry 2014; 18:23-27. [CrossRef]

14. Mackin P. Cardiac side effects of psychiatric drugs. Hum Psychopharmacol 2008; 23(Suppl.1):3-14.[CrossRef]

15. Koleva HK, Erickson MA, Vanderlip ER, Tansey J, Mac J, Fiedorowicz JG. 3 case reports of edema associated with quetiapine. Ann Clin Psychiatry 2009; 21:77-80.

16. Nayak V, Chogtu B, Devaramane V, Bhandary PV. Pedal edema with olanzepine. Indian J Pharmacol 2009; 41:49-50. [CrossRef]

17. Akin S, Bahat G, Tufan F, Saka B, Oztop N, Erten N, et al. Olanzapine as a cause of peripheric edema in an elderly man. Aging Clin Exp Res 2013; 25:115-117. [CrossRef]

18. Munshi S, Mukherjee S, Saha I, Sen S. Pedal edema associated with atypical antipsychotics. Indian J Pharmacol 2016; 48:88- 90. [CrossRef]

19. Ku HL, Su TP, Chou YH. Ziprasidone-associated pedal edema in the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:963-964. [CrossRef]